Cargando…

How Common Is Pre-Existing Cardiovascular Disease in Cancer Patients: What Do We Know? Does It Matter?

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Mamas, Mamas A., Matetic, Andrija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270616/ https://www.ncbi.nlm.nih.gov/pubmed/35818543 http://dx.doi.org/10.1016/j.jaccao.2022.05.001

Ejemplares similares

Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention
por: Bashar, Hussein, et al.
Publicado: (2022)

Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)

Dark matter: what do we really know
por: Tao, C
Publicado: (2013)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Effect of Pneumococcal Vaccine on Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
por: Jaiswal, Vikash, et al.
Publicado: (2022)

Relic gravitons from the pre-big bang: what we know and what we do not know
por: Gasperini, M.
Publicado: (1996)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Prevalence, characteristics and mortality of cancer patients undergoing pericardiocentesis in the United States between 2004 and 2017
por: Matetic, Andrija, et al.
Publicado: (2022)

COVID-19 and Cardiovascular Surgery. Do We Know What We Are Dealing With?
por: Almeida, Rui M. S., et al.
Publicado: (2021)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Long COVID: Does It Exist? What Is It? We Can We Do For Sufferers?
por: Hoffer, Edward P.
Publicado: (2021)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019)

Clinical prediction in defined populations: a simulation study investigating when and how to aggregate existing models
por: Martin, Glen P., et al.
Publicado: (2017)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Selenium and Its Supplementation in Cardiovascular Disease—What do We Know?
por: Benstoem, Carina, et al.
Publicado: (2015)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

Protective Lung Ventilation: What Do We Know?: ‘In An Investigation, Details Matter’
por: Maslow, Andrew, et al.
Publicado: (2023)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Home sharing in marketing and tourism at a tipping point: What do we know, how do we know, and where should we be heading?
por: Lim, Weng Marc, et al.
Publicado: (2021)

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
por: Sun, Chuan-bin, et al.
Publicado: (2020)

The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
por: Goldstein, David S.
Publicado: (2021)

Foot‐and‐Mouth Disease Impact on Smallholders ‐ What Do We Know, What Don't We Know and How Can We Find Out More?
por: Knight‐Jones, T. J. D., et al.
Publicado: (2016)

How little do we know?
por: Waslekar, Sundeep
Publicado: (2007)

Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice
por: Meng, Howard, et al.
Publicado: (2012)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

The risk of viral transmission in feed: What do we know, what do we do?
por: Dee, Scott A., et al.
Publicado: (2020)

Experimental subjects do not know what we think they know
por: Field, Jared M., et al.
Publicado: (2020)

Health Statistics in Australia: What We Know and Do Not Know
por: Madden, Richard, et al.
Publicado: (2022)

Equine Crofton Weed (Ageratina spp.) Pneumotoxicity: What Do We Know and What Do We Need to Know?
por: Shapter, Frances Marie, et al.
Publicado: (2023)

The cancer-obesity connection: what do we know and what can we do?
por: Riboli, Elio
Publicado: (2014)

Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
por: Tadic, Marijana, et al.
Publicado: (2020)

Multinational monkeypox outbreak: what do we know and what should we do?
por: Memariani, Mojtaba, et al.
Publicado: (2022)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_91jfgidchcmlqu2fdq6k93ief1